CLINICAL TRIALS PROFILE FOR NICODERM CQ
✉ Email this page to a colleague
All Clinical Trials for NICODERM CQ
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00086411 ↗ | Comparing Smoking Treatment Programs for Lighter Smokers - 1 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 2003-09-01 | The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two levels of counseling. It was hypothesized that the higher level of counseling would have the highest rates of treatment completion and highest rates of abstinence. |
| NCT00086411 ↗ | Comparing Smoking Treatment Programs for Lighter Smokers - 1 | Completed | Peter Gariti | Phase 2 | 2003-09-01 | The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two levels of counseling. It was hypothesized that the higher level of counseling would have the highest rates of treatment completion and highest rates of abstinence. |
| NCT00086411 ↗ | Comparing Smoking Treatment Programs for Lighter Smokers - 1 | Completed | University of Pennsylvania | Phase 2 | 2003-09-01 | The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two levels of counseling. It was hypothesized that the higher level of counseling would have the highest rates of treatment completion and highest rates of abstinence. |
| NCT00139516 ↗ | Chinese Community Smoking Cessation Project | Completed | National Heart, Lung, and Blood Institute (NHLBI) | N/A | 2001-09-01 | The study has two objectives/aims: Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months |
| NCT00139516 ↗ | Chinese Community Smoking Cessation Project | Completed | University of California, San Francisco | N/A | 2001-09-01 | The study has two objectives/aims: Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NICODERM CQ
Condition Name
Clinical Trial Locations for NICODERM CQ
Trials by Country
Clinical Trial Progress for NICODERM CQ
Clinical Trial Phase
Clinical Trial Sponsors for NICODERM CQ
Sponsor Name
